These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9097390

  • 1. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N, Farde L, Halldin C, Swahn CG.
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [Abstract] [Full Text] [Related]

  • 2. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N, Galineau L, Willeit M, Mizrahi R, Bloomfield PM, Seeman P, Houle S, Kapur S, Wilson AA.
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [Abstract] [Full Text] [Related]

  • 3. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis.
    Hietala J, Någren K, Lehikoinen P, Ruotsalainen U, Syvälahti E.
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):210-7. PubMed ID: 10027776
    [Abstract] [Full Text] [Related]

  • 4. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
    Kobayashi K, Inoue O, Watanabe Y, Onoe H, Långström B.
    J Neural Transm Gen Sect; 1995 Feb; 100(2):147-51. PubMed ID: 8962684
    [Abstract] [Full Text] [Related]

  • 5. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N, Wilson AA, Houle S, Kapur S.
    Biol Psychiatry; 2004 Jun 15; 55(12):1188-94. PubMed ID: 15184038
    [Abstract] [Full Text] [Related]

  • 6. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 7. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A, Torstenson R, Hartvig P, Carlsson A, Sonesson C, Waters N, Tedroff J, Långström B.
    Neuropharmacology; 1999 Mar 01; 38(3):331-8. PubMed ID: 10219971
    [Abstract] [Full Text] [Related]

  • 8. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K.
    Synapse; 2001 Aug 01; 41(2):87-95. PubMed ID: 11400175
    [Abstract] [Full Text] [Related]

  • 9. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.
    Bischoff S, Gunst F.
    J Recept Signal Transduct Res; 1997 Aug 01; 17(1-3):419-31. PubMed ID: 9029505
    [Abstract] [Full Text] [Related]

  • 10. Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride.
    Seneca N, Finnema SJ, Farde L, Gulyás B, Wikström HV, Halldin C, Innis RB.
    Synapse; 2006 Apr 01; 59(5):260-9. PubMed ID: 16416444
    [Abstract] [Full Text] [Related]

  • 11. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.
    Wang GJ, Volkow ND, Fowler JS, Logan J, Pappas NR, Wong CT, Hitzemann RJ, Netusil N.
    J Nucl Med; 1999 Aug 01; 40(8):1285-91. PubMed ID: 10450679
    [Abstract] [Full Text] [Related]

  • 12. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
    Halldin C, Farde L, Högberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG.
    J Nucl Med; 1995 Jul 01; 36(7):1275-81. PubMed ID: 7790956
    [Abstract] [Full Text] [Related]

  • 13. Effects of amphetamine and evoked dopamine release on [11C]raclopride binding in anesthetized cats.
    Ginovart N, Hassoun W, Le Cavorsin M, Veyre L, Le Bars D, Leviel V.
    Neuropsychopharmacology; 2002 Jul 01; 27(1):72-84. PubMed ID: 12062908
    [Abstract] [Full Text] [Related]

  • 14. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.
    Synapse; 2004 Jun 01; 52(3):188-208. PubMed ID: 15065219
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique.
    Sasaki T, Ishiwata K, Murata T, Senda M.
    Synapse; 2002 Apr 01; 44(1):42-50. PubMed ID: 11842445
    [Abstract] [Full Text] [Related]

  • 16. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
    Farde L, Eriksson L, Blomquist G, Halldin C.
    J Cereb Blood Flow Metab; 1989 Oct 01; 9(5):696-708. PubMed ID: 2528555
    [Abstract] [Full Text] [Related]

  • 17. Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.
    Sóvágó J, Farde L, Halldin C, Schukin E, Schou M, Laszlovszky I, Kiss B, Gulyás B.
    Brain Res Bull; 2005 Oct 15; 67(3):219-24. PubMed ID: 16144658
    [Abstract] [Full Text] [Related]

  • 18. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R, Lieberman J, Angrist B, Pappas N, MacGregor R.
    Synapse; 1994 Apr 15; 16(4):255-62. PubMed ID: 8059335
    [Abstract] [Full Text] [Related]

  • 19. Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.
    Olsson H, Farde L.
    Neuroimage; 2001 Oct 15; 14(4):936-45. PubMed ID: 11554812
    [Abstract] [Full Text] [Related]

  • 20. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P, Gjedde A, Olsen AK, Jensen SB, Munk OL, Watanabe H, Cumming P.
    Synapse; 2004 Sep 15; 53(4):222-33. PubMed ID: 15266554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.